Assessment of adherence to product dosing in a pilot microbicide study

Kathleen Hogarty1, Andrea Kasowitz, Betsy C Herold

  • 1Department of Medicine, Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1090, New York, NY 10029, USA.

Abstract

Insights

Applicator staining accurately and affordably tracks adherence in microbicide studies, correlating well with self-reports. This method can improve future adherence assessments for microbicide product dosing.

Area of Science:

  • Reproductive Health
  • Clinical Trials
  • Pharmaceutical Sciences

Background:

  • Assessing adherence to microbicide products is crucial for trial efficacy.
  • Traditional adherence measures like self-reporting can be unreliable.

Purpose of the Study:

  • To evaluate applicator staining as a reliable adherence marker in microbicide studies.
  • To compare observer assessments of stained applicators with participant self-reports.

Main Methods:

  • Subjects in a 14-day microbicide trial returned used and unused applicators.
  • Applicators were stained with trypan blue, and observers assessed their use.
  • Observer ratings were compared against participant self-reports.

Main Results:

  • Applicator staining showed high agreement (98-99%) with participant self-reports.
  • The method accurately distinguished between various applicator usage scenarios (76-87%).
  • No significant differences were found between individual or batch staining methods.

Conclusions:

  • Applicator staining is an accurate, cost-effective method for assessing adherence in short-term microbicide trials.
  • This technique offers a valuable tool for improving adherence monitoring in future microbicide research.

Related Concept Videos

Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Modified-Release Drug Delivery Systems: Bioavailability01:30

Modified-Release Drug Delivery Systems: Bioavailability

Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...